We are live on ! Find out more
PHIO icon

Phio Pharmaceuticals
PHIO

3 hedge funds and large institutions have $3.06M invested in Phio Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.71% more ownership

Funds ownership: 12.11% → 12.82% (+0.71%)

0% more funds holding

Funds holding: 3 → 3 (0)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $18K

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Bison Wealth
Bison Wealth
Georgia
-$13K
2
Jane Street
Jane Street
New York
-$5K

PHIO Hedge Fund Activity: Q3 2015 in Review

3 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals (PHIO) for Q3 2015, worth a combined $3.06M — down 19% from $3.78M a quarter earlier.

Fund positioning in PHIO was balanced in Q3 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Bison Wealth, cutting an estimated $13K.

  • 3 institutional investors held Phio Pharmaceuticals (PHIO) as of Q3 2015, unchanged from Q2 2015.
  • Funds reported $3.06M of Phio Pharmaceuticals stock for Q3 2015, down 19% quarter-over-quarter.
  • 0 funds opened new Phio Pharmaceuticals positions in Q3 2015 and 0 closed out.
  • The largest Phio Pharmaceuticals seller in Q3 2015 was Bison Wealth, an estimated $13K sold.

Based on aggregated 13F filings for Q3 2015.